Cargando…
Delays and routes to diagnosis of neuroendocrine tumours
BACKGROUND: Neuroendocrine tumours are uncommon tumours; there is often a long period between the onset of symptoms and diagnosis. This study aims to address the symptoms prior to diagnosis of people with known neuroendocrine tumours and also the involvement of healthcare providers prior to the diag...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240263/ https://www.ncbi.nlm.nih.gov/pubmed/30445941 http://dx.doi.org/10.1186/s12885-018-5057-3 |
_version_ | 1783371608979668992 |
---|---|
author | Basuroy, Ron Bouvier, Catherine Ramage, John Keith Sissons, Maia Srirajaskanthan, Raj |
author_facet | Basuroy, Ron Bouvier, Catherine Ramage, John Keith Sissons, Maia Srirajaskanthan, Raj |
author_sort | Basuroy, Ron |
collection | PubMed |
description | BACKGROUND: Neuroendocrine tumours are uncommon tumours; there is often a long period between the onset of symptoms and diagnosis. This study aims to address the symptoms prior to diagnosis of people with known neuroendocrine tumours and also the involvement of healthcare providers prior to the diagnosis. METHODS: A web based survey was designed to cover two broad areas of patient symptoms and healthcare interactions prior to diagnosis. This was tested and adapted by patient and clinician input prior to distribution via Survey Monkey. RESULTS: The results demonstrated a median time from first symptom to diagnosis of 53.8 months. The most frequent initial symptoms were of pain, change in bowel habit and fatigue. 31% of respondents noted weight loss prior to diagnosis. 80% of respondents visited their GP regarding the symptoms a median of 11 times. 58% of respondents were referred to secondary care where they were seen a median 3 times. 30% presented acutely to A&E and this led to their diagnosis. CONCLUSION: In conclusion, there is a long time from onset of symptoms to diagnosis in all types of NETs. This is despite many respondents having alarm symptoms at diagnosis. Further education and awareness regarding malignancy may help with earlier diagnosis. |
format | Online Article Text |
id | pubmed-6240263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62402632018-11-23 Delays and routes to diagnosis of neuroendocrine tumours Basuroy, Ron Bouvier, Catherine Ramage, John Keith Sissons, Maia Srirajaskanthan, Raj BMC Cancer Research Article BACKGROUND: Neuroendocrine tumours are uncommon tumours; there is often a long period between the onset of symptoms and diagnosis. This study aims to address the symptoms prior to diagnosis of people with known neuroendocrine tumours and also the involvement of healthcare providers prior to the diagnosis. METHODS: A web based survey was designed to cover two broad areas of patient symptoms and healthcare interactions prior to diagnosis. This was tested and adapted by patient and clinician input prior to distribution via Survey Monkey. RESULTS: The results demonstrated a median time from first symptom to diagnosis of 53.8 months. The most frequent initial symptoms were of pain, change in bowel habit and fatigue. 31% of respondents noted weight loss prior to diagnosis. 80% of respondents visited their GP regarding the symptoms a median of 11 times. 58% of respondents were referred to secondary care where they were seen a median 3 times. 30% presented acutely to A&E and this led to their diagnosis. CONCLUSION: In conclusion, there is a long time from onset of symptoms to diagnosis in all types of NETs. This is despite many respondents having alarm symptoms at diagnosis. Further education and awareness regarding malignancy may help with earlier diagnosis. BioMed Central 2018-11-16 /pmc/articles/PMC6240263/ /pubmed/30445941 http://dx.doi.org/10.1186/s12885-018-5057-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Basuroy, Ron Bouvier, Catherine Ramage, John Keith Sissons, Maia Srirajaskanthan, Raj Delays and routes to diagnosis of neuroendocrine tumours |
title | Delays and routes to diagnosis of neuroendocrine tumours |
title_full | Delays and routes to diagnosis of neuroendocrine tumours |
title_fullStr | Delays and routes to diagnosis of neuroendocrine tumours |
title_full_unstemmed | Delays and routes to diagnosis of neuroendocrine tumours |
title_short | Delays and routes to diagnosis of neuroendocrine tumours |
title_sort | delays and routes to diagnosis of neuroendocrine tumours |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240263/ https://www.ncbi.nlm.nih.gov/pubmed/30445941 http://dx.doi.org/10.1186/s12885-018-5057-3 |
work_keys_str_mv | AT basuroyron delaysandroutestodiagnosisofneuroendocrinetumours AT bouviercatherine delaysandroutestodiagnosisofneuroendocrinetumours AT ramagejohnkeith delaysandroutestodiagnosisofneuroendocrinetumours AT sissonsmaia delaysandroutestodiagnosisofneuroendocrinetumours AT srirajaskanthanraj delaysandroutestodiagnosisofneuroendocrinetumours |